Ms. Sharmila David Jesudason
CEO/ Co-founder
Ai-2nd Opinion
Genetics Department
Sharmila David Jesudason is the CEO and Co-founder of Ai-2nd Opinion, an innovative AI healthcare company incubated under DIC and MCIT. With a strong background as a Robotic Process Automation (RPA) consultant, Sharmila David has led numerous projects in process optimization, helping organizations automate repetitive tasks, enhance operational efficiency, and improve data management. Leveraging this expertise, Sharmila David transitioned into the healthcare AI space, and has been pivotal in developing AI models for breast cancer, lung, cardio, and hepatorenal diagnosis. She works closely with a team of IT professionals and renowned advisors, medical experts driving innovation in precision medicine, and is visionary in bringing breakthrough technology originating from Qatar taking to global stage in the healthcare industry.
